Webcast: Addressing and Treating Iron Deficiency to Improve Symptoms and Outcomes in Patients with Heart Failure
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2023-12/Addressing%20and%20Treating%20Iron%20Deficiency%20-%201200x630.png?itok=-UnRYnPp)
Iron deficiency (ID) with or without anemia is a common comorbidity in patients with heart failure (HF), and it can have significant impacts on morbidity and mortality.
Category
- CMHC
Format
- Video
- Webinar recorded
Credits
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
Escape Room Experience: Individualizing Treatment for Patients with Chronic Kidney Disease and Type 2 Diabetes
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2024-02/Individualizing%20Treatment%20for%20Patients%20with%20Chronic%20Kidney%20020724.ai_1200x630.jpg?itok=e4XrtJJ9)
The coexistence of type 2 diabetes and chronic kidney disease significantly exacerbates cardiovascular and renal morbidity and mortality compared to either condition alone. Even with the advent of newer therapies in patients with T2D and CKD, such as sodium-glucose cotransporter-2 (SGLT-2) inhibi
Category
- CMHC
Format
- Self-study / Enduring
Credits
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
2023 Women’s Masterclass On Demand
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2023-08/Womens%20Masterclass%20Event%20App%20Icon%20053023-02.jpg?itok=xDjwpSk3)
The recordings from the 2023 Women’s Cardiometabolic Health and Wellness Masterclass are now available. Led by co-chairs Pam R. Taub, MD and Erin D.
Category
- CMHC
Format
- Conference / meeting
- Video
Credits
- 12.00 ACPE Pharmacy
- 12.00 AMA PRA Category 1 Credit™
- 12.00 ANCC
- 12.00 Participation
The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2024-05/Individualizing%20Treatment%20for%20Patients%20with%20Chronic%20Kidney%20050724.ai_1200x630.png?itok=P7wYqiSM)
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects an estimated 25-30% of people in the United States and can often progress to Metabolic dysfunction-associated steatohepatitis (MASH) and cirrhosis.
Category
- CMHC
- TME
Format
- Self-study / Enduring
Credits
- 0.75 ACPE Pharmacy
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
- 0.75 Participation
Clinical Insights into Psoriasis in Patients of Color: Bringing New Data to Light
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2024-05/Virtual%20Webcast%20Clinical%20Insights%20into%20Psoriasis%20in%20Patients%20of%20Color%20030424_800x385.jpg?itok=HEsuRVLN)
Various gaps in the management of psoriasis in patients with SOC persist due to a lack of training for dermatology practitioners. As a result, patients with SOC are often misdiagnosed, experience more severe disease, and experience more disease burden.
Category
- LivDerm
Format
- Video
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
Exploring Novel Strategies for LDL-C Combination Therapy to Decrease ASCVD Risk: A Paradigm Shift
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2024-05/1682%20Compendium%20052224_1200x630.jpg?itok=2Bud2pqa)
Effectively and safely lowering LDL-C is essential to prevent and reduce the risk of recurrent ASCVD events.
Category
- CMHC
Format
- Self-study / Enduring
Credits
- 1.50 ACPE Pharmacy
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 1.50 CDE
- 1.50 Participation
According to the Patient: Alopecia Areata in Adolescence
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2024-04/According%20to%20the%20Patient%20-%20Alopecia%20Areata%20in%20Adolescence%20041524_800x385.jpg?itok=PGGaNzZe)
The management of AA in adolescents presents various challenges to dermatology professionals, including identification of AA, limited effective treatment options, and high disease burden.
Category
- LivDerm
- TME
Format
- Video
Credits
- 1.00 AAPA Category I CME
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
Psoriasis in Skin of Color Unplugged: Addressing the Barriers to Patient Care and Relief
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2024-05/Virtual%20Webcast%20Psoriasis%20in%20Skin%20of%20Color%20-%20Addressing%20the%20Barriers%20to%20Patient%20050924_800x450-04%20%282%29.jpg?itok=MgJzxPXo)
Various gaps in the management of psoriasis patients with skin of color (SOC) persist due to a lack of training on SOC and inherent barriers to care. As a result, psoriasis patients with SOC are often misdiagnosed, experience more severe disease, and experience more disease burden.
Category
- LivDerm
- TME
Format
- Video
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
Advances in Non-Steroidal Topicals: PDE-4 Inhibitors for Seborrheic Dermatitis and Beyond
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2024-06/Advances%20in%20Non-Steroidal%20Topicals%20052924_800x450-04%20%281%29.jpg?itok=2oDZxhj7)
Traditional treatments for seborrheic dermatitis, including oral and topical steroids, present a variety of challenges including lack of efficacy, adverse events with long-term use, limitations for adherence, and the inability to treat both hair- and non-hair-bearing areas.
Category
- LivDerm
- TME
Format
- Video
Credits
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
- 0.75 Participation